Rossi NF, Chen H.
Source
Departments of Medicine and Physiology, Wayne State University School of Medicine and John D. Dingell VA Medical Center, Detroit, Michigan, USA.
Previously it has been shown that
endothelin (ET-1) elicits pressor response and
induces secretion of vasopressin (AVP). In this article the authors hypothesize
that the pressor response and AVP secretion in response to ET-1 microinjection into
subfornical organ (SFO) are mediated by glutamatergic receptor within the PVN.
The reason the authors chose glutamatergic receptors is because they are shown
to mediate ET-1-induced AVP secretion in vitro. In
this study sinoaortic denervated male Long Evans rats were implanted with icv
cannulae bilaterally in the SFO and PVN. ET-1 was directly injected into
the SFO resulting in an increase in mean arterial pressure (MAP) and mean
plasma AVP level, these changes were blocked by selective ET (A) inhibition.
Pretreatment with an NMDA blocker diclozipine into PVN bilaterally
showed no changes in MAP and MPV. However, when
6-cyano-7-nitroquinoxaline-2,3-dione was injected bilaterally in the PVN
prevented the pressor response and also inhibited AVP secretion. In conclusion
both the pressor response and AVP secretion in response to ET-1 acting at the SFO are mediated
by a non-NMDA, most likely an aminopropionic acid glutamatergic receptor within
the PVN.
-Madhan
-Madhan
No comments:
Post a Comment